tinea%20capitis%20(pediatric)
TINEA CAPITIS (PEDIATRIC)
Tinea capitis lesions are a type of contagious dermatophytosis that are found on the scalp, hair follicles and/or surrounding skin.
It is most common in the crowded areas as infection originates from contact with a pet or an infected person and asymptomatic carriage persists indefinitely.
It primarily affects children 3-7 year of age.
The causative agents are the genus Trichophyton and Microsporum.
Cardinal clinical feature is the combination of inflammation with hair breakage and loss.

Tinea%20capitis%20(pediatric) Signs and Symptoms

Introduction

  • Most common in crowded areas as infection originates from contact w/ a pet or an infected person, & asymptomatic carriage persists indefinitely
  • Primarily affects children 3-7 years of age

Definition

  • Tinea capitis lesions are a type of contagious dermatophytosis that are found on the scalp, hair follicles &/or surrounding skin

Etiology

  • Causative agents are the two genera: Trichophyton & Microsporum
    • T tonsurans is the most common; M canis is the second most common
Causative Agents
  • Large-spored endothrix pattern chains of large spores w/in hair (Trichophyton tonsurans, T violaceum)
  • Large-spored ectothrix (T verrucosum, T mentagrophytes)
  • Small-spored ectothrix randomly arranged in masses inside & on the surface of the hair shaft (Microsporum canis, M audouinii)

Signs and Symptoms

  • Cardinal clinical feature is the combination of inflammation w/ hair breakage & loss
  • Patients present w/ any of several different clinical patterns of Tinea capitis infection
  • Cervical or occipital lymphadenopathy & some alopecia are typically present
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
02 Apr 2019
Using preventive zinc and micronutrient powder supplementation does not appear to improve growth in children, a recent study has found.
Audrey Abella, 14 Oct 2020
Findings from the phase IIa T1GER study revealed the therapeutic potential of the monoclonal antibody golimumab for children and young adults with type 1 diabetes (T1D).
Roshini Claire Anthony, 28 Sep 2020

A 4-week course of amoxicillin-clavulanate in children with protracted bacterial bronchitis (PBB) does not improve cough resolution rates compared with a 2-week course, according to a study from Australia. However, the longer course may significantly extend time to first cough exacerbation.